France
· Delayed Price · Currency is EUR Affluent Medical Statistics
Total Valuation
Affluent Medical has a market cap or net worth of EUR 56.25 million. The enterprise value is 72.84 million.
| Market Cap | 56.25M |
| Enterprise Value | 72.84M |
Important Dates
The next estimated earnings date is Friday, December 27, 2024.
| Earnings Date | Dec 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Affluent Medical has 39.34 million shares outstanding. The number of shares has increased by 35.96% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 39.34M |
| Shares Change (YoY) | +35.96% |
| Shares Change (QoQ) | +6.01% |
| Owned by Insiders (%) | 1.42% |
| Owned by Institutions (%) | 0.35% |
| Float | 5.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 35.18 |
| PB Ratio | 1.82 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.27 |
| EV / Sales | 56.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -9.79 |
Financial Position
The company has a current ratio of 0.45, with a Debt / Equity ratio of 0.67.
| Current Ratio | 0.45 |
| Quick Ratio | 0.37 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.35 |
| Interest Coverage | -36.90 |
Financial Efficiency
Return on equity (ROE) is -52.40% and return on invested capital (ROIC) is -20.84%.
| Return on Equity (ROE) | -52.40% |
| Return on Assets (ROA) | -17.51% |
| Return on Capital (ROIC) | -20.84% |
| Revenue Per Employee | 19,621 |
| Profits Per Employee | -258,197 |
| Employee Count | 63 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.42% in the last 52 weeks. The beta is 0.61, so Affluent Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +4.42% |
| 50-Day Moving Average | 1.62 |
| 200-Day Moving Average | 1.76 |
| Relative Strength Index (RSI) | 44.97 |
| Average Volume (20 Days) | 5,343 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Affluent Medical had revenue of EUR 1.30 million and -17.04 million in losses. Loss per share was -0.54.
| Revenue | 1.30M |
| Gross Profit | -1.05M |
| Operating Income | -16.79M |
| Pretax Income | -17.19M |
| Net Income | -17.04M |
| EBITDA | -14.75M |
| EBIT | -16.79M |
| Loss Per Share | -0.54 |
Balance Sheet
The company has 915,000 in cash and 17.50 million in debt, giving a net cash position of -16.59 million or -0.42 per share.
| Cash & Cash Equivalents | 915,000 |
| Total Debt | 17.50M |
| Net Cash | -16.59M |
| Net Cash Per Share | -0.42 |
| Equity (Book Value) | 26.06M |
| Book Value Per Share | 0.79 |
| Working Capital | -7.93M |
Cash Flow
In the last 12 months, operating cash flow was -7.23 million and capital expenditures -214,000, giving a free cash flow of -7.44 million.
| Operating Cash Flow | -7.23M |
| Capital Expenditures | -214,000 |
| Free Cash Flow | -7.44M |
| FCF Per Share | -0.19 |
Margins
| Gross Margin | -81.31% |
| Operating Margin | -1,296.60% |
| Pretax Margin | -1,327.41% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Affluent Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.96% |
| Shareholder Yield | -35.96% |
| Earnings Yield | -38.01% |
| FCF Yield | -13.22% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |